These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3775869)
1. The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis. Orozco LC; Quintana FO; Beltrán RM; de Moreno I; Wasserman M; Rodriguez G Tubercle; 1986 Jun; 67(2):91-7. PubMed ID: 3775869 [TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses. Kradolfer F; Schnell R Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315 [No Abstract] [Full Text] [Related]
3. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis. Kradolfer F; Schnell R Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314 [No Abstract] [Full Text] [Related]
4. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. Labana S; Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2002 Oct; 20(4):301-4. PubMed ID: 12385689 [TBL] [Abstract][Full Text] [Related]
5. Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid. Quenelle DC; Winchester GA; Staas JK; Barrow EL; Barrow WW Antimicrob Agents Chemother; 2001 Jun; 45(6):1637-44. PubMed ID: 11353605 [TBL] [Abstract][Full Text] [Related]
6. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
7. Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis. Paramasivan CN; Kubendiran G; Herbert D Indian J Med Res; 1998 Oct; 108():115-9. PubMed ID: 9805839 [TBL] [Abstract][Full Text] [Related]
8. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial. Tousek J; Votruba R Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071 [No Abstract] [Full Text] [Related]
9. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic. Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404 [No Abstract] [Full Text] [Related]
10. Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran). Trnka L; Kvapilová M; Mison P Chemotherapy; 1976; 22(6):353-61. PubMed ID: 954481 [TBL] [Abstract][Full Text] [Related]
11. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
12. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore. Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598 [TBL] [Abstract][Full Text] [Related]
14. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis]. Szymański A Pneumonol Pol; 1976 Mar; 44(3):227-35. PubMed ID: 1257096 [No Abstract] [Full Text] [Related]
15. Isoniazid-rifampin regimens for tuberculosis. Farer LS; Long MW; Snider DE Ann Intern Med; 1981 Oct; 95(4):518-9. PubMed ID: 7283312 [No Abstract] [Full Text] [Related]
16. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142 [TBL] [Abstract][Full Text] [Related]
17. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis. Konno K; Oizumi K; Yamada S; Ogata K; Sato M Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624 [No Abstract] [Full Text] [Related]
18. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related]
19. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Castelo A; Jardim JR; Goihman S; Kalckman AS; Dalboni MA; da Silva EA; Haynes RB Lancet; 1989 Nov; 2(8673):1173-6. PubMed ID: 2572899 [TBL] [Abstract][Full Text] [Related]
20. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases. Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668 [No Abstract] [Full Text] [Related] [Next] [New Search]